BI 764524 / Boehringer Ingelheim  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BI 764524 / Boehringer Ingelheim
NCT06321302: A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

Recruiting
2
178
US
BI 764524, Sham comparator to BI 764524, Aflibercept (Eylea®) - US only
Boehringer Ingelheim
Diabetic Retinopathy
07/26
11/26
HORNBILL, NCT04424290: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia

Completed
1/2
45
Europe, US
BI 764524, Sham control of BI 764524
Boehringer Ingelheim
Diabetic Retinopathy
04/23
04/23

Download Options